ABK Biomedical

Halifax, Canada

ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.

$35.0M raised

Oct 2025

Series D

Biotechnology Health Care Medical Medical Device

Top Investors

Sante VenturesJP MorganF-PrimeEight Roads VenturesInnovacorp

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ABK Biomedical

How much funding has ABK Biomedical raised?

ABK Biomedical has raised $35.0M in total funding. The most recent round was Series D. The last funding was announced in October 2025.

Who are ABK Biomedical's investors?

ABK Biomedical's investors include Sante Ventures, JP Morgan, F-Prime, Eight Roads Ventures, Innovacorp.

Where is ABK Biomedical headquartered?

ABK Biomedical is headquartered in Halifax, Canada.

What does ABK Biomedical do?

ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.

What stage is ABK Biomedical at?

ABK Biomedical is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 14, 2025.

MLA

"ABK Biomedical — Funding & Investors." VCBacked, October 14, 2025, https://www.vcbacked.co/company/abk-biomedical. Accessed June 5, 2026.

APA

VCBacked. (2025). ABK Biomedical — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/abk-biomedical

Wikipedia (cite web)

{{cite web |title=ABK Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/abk-biomedical |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 14, 2025.

Similar Companies in Biotechnology